I had the privilege of trying the Micro-ECoG from Blackrock. I was quite impressed how professional it looked. It was robust, yet extremely delicate. We had a challenging surgery and the device worked solidly first time.
We weren’t happy with the standard of care and now we are working with Blackrock on next-generation devices.
I have made it my life’s ambition to address dementia. Blackrock has helped me understand the challenges I face in building a venture in neurotech.
Blackrock is the clear technology leader for human microelectrode arrays. They are the only ones whose devices have been implanted chronically in humans. If you want single neuron resolution in people, you can’t use anyone else’s technology at this point.